Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ramipril 10mg capsules
0205051R0AAADAD
|
Ramipril | Ramipril | Cardiovascular System | 1,874,144 |
|
Ramipril 2.5mg capsules
0205051R0AAABAB
|
Ramipril | Ramipril | Cardiovascular System | 1,323,172 |
|
Ramipril 5mg capsules
0205051R0AAACAC
|
Ramipril | Ramipril | Cardiovascular System | 1,295,933 |
|
Ramipril 1.25mg capsules
0205051R0AAAAAA
|
Ramipril | Ramipril | Cardiovascular System | 675,626 |
|
Ramipril 10mg tablets
0205051R0AAANAN
|
Ramipril | Ramipril | Cardiovascular System | 151,369 |
|
Ramipril 2.5mg tablets
0205051R0AAALAL
|
Ramipril | Ramipril | Cardiovascular System | 147,989 |
|
Ramipril 5mg tablets
0205051R0AAAMAM
|
Ramipril | Ramipril | Cardiovascular System | 141,215 |
|
Ramipril 1.25mg tablets
0205051R0AAAKAK
|
Ramipril | Ramipril | Cardiovascular System | 73,145 |
|
Ramipril 2.5mg/5ml oral solution sugar free
0205051R0AAATAT
|
Ramipril | Ramipril | Cardiovascular System | 2,574 |
|
Tritace 10mg tablets
0205051R0BBAIAN
|
Tritace | Ramipril | Cardiovascular System | 560 |
|
Tritace 5mg tablets
0205051R0BBAHAM
|
Tritace | Ramipril | Cardiovascular System | 415 |
|
Tritace 2.5mg tablets
0205051R0BBAGAL
|
Tritace | Ramipril | Cardiovascular System | 393 |
|
Tritace 1.25mg tablets
0205051R0BBAFAK
|
Tritace | Ramipril | Cardiovascular System | 65 |
|
Tritace titration pack tablets
0205051R0BBAJAU
|
Tritace | Ramipril | Cardiovascular System | 32 |
|
Ramipril 10mg/5ml oral suspension
0205051R0AAAWAW
|
Ramipril | Ramipril | Cardiovascular System | 30 |
|
Ramipril 10mg/5ml oral solution
0205051R0AAAHAH
|
Ramipril | Ramipril | Cardiovascular System | 27 |
|
Ramipril 5mg/5ml oral liquid
0205051R0AAAEAE
|
Ramipril | Ramipril | Cardiovascular System | 23 |
|
Ramipril 5mg/5ml oral solution sugar free
0205051R0AAAZAZ
|
Ramipril | Ramipril | Cardiovascular System | 10 |
|
Ramipril 10mg/5ml oral solution sugar free
0205051R0AABABA
|
Ramipril | Ramipril | Cardiovascular System | 9 |
|
Ramipril 2.5mg/5ml oral liquid
0205051R0AAAFAF
|
Ramipril | Ramipril | Cardiovascular System | 5 |
|
Ramipril 1.25mg/5ml oral liquid
0205051R0AAAGAG
|
Ramipril | Ramipril | Cardiovascular System | 4 |
|
Generic Tritace titration pack tablets
0205051R0AAAUAU
|
Ramipril | Ramipril | Cardiovascular System | 1 |
|
Generic Tritace titration pack capsules
0205051R0AAAIAI
|
Ramipril | Ramipril | Cardiovascular System | No data available |
|
Lopace 10mg capsules
0205051R0BCACAD
|
Lopace | Ramipril | Cardiovascular System | No data available |
|
Lopace 2.5mg capsules
0205051R0BCAAAB
|
Lopace | Ramipril | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.